Response to oral sucrosomial iron supplementation in patients undergoing bariatric surgery. The BARI-FER study

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

20 Cites (Scopus)

Resum

© 2017 SEEN y SED Background Chronic intravenous iron administration is often required after bariatric surgery. Oral sucrosomial iron has a particular form of absorption and may represent an alternative treatment. Objective To assess the effect of switching to oral sucrosomial iron in patients receiving intravenous iron supplementation after bariatric surgery. Patients and methods A case–control study was conducted on 40 women of childbearing age, of whom 20 were switched to oral sucrosomial iron, while 20 patients continued on intravenous iron sucrose every three months. Results No significant differences were seen in Hb, ferritin, and TSI levels before and after three months of treatment with sucrosomial iron. Conclusion Oral sucrosomial iron could be an alternative in patients who require parenteral treatment with iron after bariatric surgery.
Idioma originalAnglès
Pàgines (de-a)17-20
RevistaEndocrinologia, Diabetes y Nutricion
Volum65
Número1
DOIs
Estat de la publicacióPublicada - 1 de gen. 2018

Fingerprint

Navegar pels temes de recerca de 'Response to oral sucrosomial iron supplementation in patients undergoing bariatric surgery. The BARI-FER study'. Junts formen un fingerprint únic.

Com citar-ho